Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025
Inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS), and resistant starch all fall into this category
Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives
The agency warned consumers and doctors might still experience "limited localized supply disruptions" as the products are shipped from drug factories to distributors to pharmacies
It can trigger fraud investigations if the pattern suggests systematic upcoding or indication mismatches